World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
9789
World Ranking
3986
National Ranking
1821

Rosemary Rochford publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Rosemary Rochford sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 158 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Rosemary Rochford D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Rosemary Rochford sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Rosemary Rochford is affiliated with the University of Colorado Anschutz Medical Campus in the United States. Their research is principally situated within the broad field of Medicine, with a focus on several subfields including Oncology, Infectious Diseases, Immunology, Epidemiology, and Public Health, Environmental and Occupational Health.

The scientist's work encompasses multiple key topics, prominently featuring studies on viral-associated cancers and disorders, cytomegalovirus and herpesvirus research, immune cell function and interaction, parvovirus B19 infection studies, lymphoma diagnosis and treatment, SARS-CoV-2 and COVID-19 research, as well as neonatal health and biochemistry.

Rosemary Rochford has contributed to several recent papers, notable among them are:

  • "Burkitt lymphoma" (2022) published in Nature Reviews Disease Primers
  • "CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells" (2020) published in Journal of Virology
  • "Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183" (2022) published in Nature Communications
  • "Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda" (2021) published in Nature Communications
  • "Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA" (2021) published in Journal of Clinical Microbiology

The researcher frequently publishes in a set of recurring venues that include:

  • The Journal of Infectious Diseases
  • Infectious Agents and Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Research Square (Research Square)
  • Nature Communications

Collaborations have been an important aspect of their work. Frequent coauthors include Katherine R. Sabourin, Conner Jackson, Denise Whitby, Robert Newton, and Sidney Ogolla, with multiple joint publications contributing to shared research goals.

The scope and diversity of Rosemary Rochford's scientific output reflect sustained engagement with complex medical issues related to infectious agents, immune responses, and oncology, applying both clinical and molecular approaches within their areas of study.

Best Publications

  • Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

    Luca G. Guidotti;Rosemary Rochford;Josan Chung;Max Shapiro

  • Burkitt's lymphoma

    Elizabeth M Molyneux;Rosemary Rochford;Beverly Griffin;Robert Newton

  • Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation.

    Ann M. Moormann;Amy D. Sullivan;Rosemary A. Rochford;Stephen W. Chensue

  • Exposure to Holoendemic Malaria Results in Elevated Epstein-Barr Virus Loads in Children

    Ann M. Moormann;Kiprotich Chelimo;Odada P. Sumba;Mary L. Lutzke

  • Endemic Burkitt's lymphoma: a polymicrobial disease?

    Rosemary A. Rochford;Martin J. Cannon;Ann M. Moormann

  • Early Age at Time of Primary Epstein–Barr Virus Infection Results in Poorly Controlled Viral Infection in Infants From Western Kenya: Clues to the Etiology of Endemic Burkitt Lymphoma

    Erwan Piriou;Amolo S. Asito;Amolo S. Asito;Peter Odada Sumba;Nancy Fiore

  • Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases

    Bradley M. Haverkos;Zenggang Pan;Alejandro A. Gru;Aharon G. Freud

  • Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression

    Elizabeth T. Abrams;Heidi Brown;Stephen W. Chensue;Gareth D. H. Turner

  • TNF-α Inhibits HIV-1 Replication in Peripheral Blood Monocytes and Alveolar Macrophages by Inducing the Production of RANTES and Decreasing C-C Chemokine Receptor 5 (CCR5) Expression

    Brian R. Lane;David M. Markovitz;Nina L. Woodford;Rosemary Rochford

  • C1q and MBL, components of the innate immune system, influence monocyte cytokine expression.

    Deborah A. Fraser;Suzanne S. Bohlson;Nijole Jasinskiene;Nenoo Rawal

  • Relationship between polyadenylated and nonpolyadenylated herpes simplex virus type 1 latency-associated transcripts.

    G B Devi-Rao;S A Goodart;L M Hecht;R Rochford

  • KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo

    William Wu;Jeffrey Vieira;Jeffrey Vieira;Nancy Fiore;Nancy Fiore;Prabal Banerjee;Prabal Banerjee

  • Spatial distribution of Burkitt’s lymphoma in Kenya and association with malaria risk

    Jeanette J. Rainey;Walter O. Mwanda;Priscilla Wairiumu;Ann M. Moormann

  • Alpha/Beta Interferons Regulate Murine Gammaherpesvirus Latent Gene Expression and Reactivation from Latency

    Erik S. Barton;Mary L. Lutzke;Rosemary Rochford;Herbert W. Virgin

  • HIV/AIDS and lipodystrophy: Implications for clinical management in resource-limited settings

    Julia L Finkelstein;Pooja Gala;Rosemary Rochford;Marshall J Glesby

  • Exposure to Holoendemic Malaria Results in Suppression of Epstein-Barr Virus-Specific T Cell Immunosurveillance in Kenyan Children

    Ann M. Moormann;Kiprotich Chelimo;Peter Odada Sumba;Daniel J. Tisch

  • Gamma Interferon Blocks Gammaherpesvirus Reactivation from Latency

    Ashley L. Steed;Erik S. Barton;Scott A. Tibbetts;Daniel L. Popkin

  • Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines

    Carrie B. Coleman;Eric M. Wohlford;Nicholas A. Smith;Christine A. King

  • Spatial clustering of endemic Burkitt's lymphoma in high-risk regions of Kenya

    Jeanette J. Rainey;Dorine Omenah;Peter Odada Sumba;Ann M. Moormann

  • Minimizing Batch Effects in Mass Cytometry Data.

    Ronald P Schuyler;Conner Jackson;Josselyn E Garcia-Perez;Ryan M Baxter

  • Malaria enhances expression of CC chemokine receptor 5 on placental macrophages

    Ariana N. Tkachuk;Ann M. Moormann;Judy A. Poore;Rosemary A. Rochford

Frequent Co-Authors

Sergio Wittlin
Sergio Wittlin Swiss Tropical and Public Health Institute
David A. Fidock
David A. Fidock Columbia University
Martin J. Cannon
Martin J. Cannon University of Arkansas for Medical Sciences
Robert U. Newton
Robert U. Newton Edith Cowan University
Susan A. Charman
Susan A. Charman Monash University
Kennan C. Marsh
Kennan C. Marsh AbbVie (United States)
Jaap M. Middeldorp
Jaap M. Middeldorp VU University Medical Center
Ric N. Price
Ric N. Price Charles Darwin University
Kelly Chibale
Kelly Chibale University of Cape Town
Clemens H. M. Kocken
Clemens H. M. Kocken Biomedical Primate Research Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers related to immunology often leads many students and professionals toward nursing and specialized healthcare roles. Programs such as Licensed Practical Nurse (LPN) degrees are a practical starting point, and finding accredited LPN programs easy to get into can accelerate entry into the healthcare field.

For those interested in advancing their qualifications, Nurse Practitioner (NP) degrees offer increased scope and specialization. Identifying the easiest NP programs to get into can help streamline the transition for busy professionals seeking flexible paths.

Psychiatric Mental Health Nurse Practitioner (PMHNP) roles closely align with immunology’s focus on neuroimmunology and the body’s response to mental health disorders. Students should consider enrolling in the top PMHNP programs that facilitate hands-on clinical experience to complement online learning.

Affordability is a critical factor when selecting advanced programs. Those searching for cost-effective options can explore cheapest psychiatric nurse practitioner programs that maintain quality education with financial accessibility in mind.

Choosing the right online degree can open diverse career pathways that intersect with immunology, offering opportunities to impact healthcare outcomes significantly.

Best Scientists Citing Rosemary Rochford

Trending Scientists

Recently Published Articles